Lainie Jorns
Family Medicine · Gulfport, MSNPI 1417191222
Payments from drug & device makers
Across 149 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$283
- AbbVie$264
- Novo Nordisk$245
- Amgen$243
- Amarin Pharma, Inc.$167
- Kowa Pharmaceuticals America, Inc.$158
- plus $839 from 18 others
What the payments were for
- Food & beverage$2,18099%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $283 |
| AbbVie(2 entities) | 20 | $264 |
| Novo Nordisk | 18 | $245 |
| Amgen | 19 | $243 |
| Amarin Pharma, Inc. | 13 | $167 |
| Kowa Pharmaceuticals America, Inc. | 11 | $158 |
| Johnson & Johnson | 9 | $120 |
| Pfizer | 9 | $118 |
| Olympus America Inc. | 2 | $90 |
| GSK | 5 | $70 |
| AstraZeneca | 4 | $53 |
| Novartis | 4 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Lilly USA, LLC | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Seqirus USA Inc | 2 | $27 |
| Merck | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 2 | $26 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYRBETRIQ$116
How this compares
$2,198 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gulfport
- Paul MatherneGulfport$14.4M
- Sean KerbyGulfport$6.6M
- Kathy KeimigGulfport$20K
- Jonathan HamiltonGulfport$16K
- Dimitrios DimitriadesGulfport$13K
- Steven SchepensGulfport$12K
- Matthew BosargeGulfport$10K
- Timothy QuinnRidgeland$8M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.